Akebia Therapeutics (AKBA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -185,176 | -130,591 | -72,421 | -143,588 | -83,534 |
| Depreciation Amortization | 28,165 | 18,541 | 9,062 | 1,189 | -60 |
| Income taxes - deferred | -4,879 | -3,602 | -2,757 | -28,338 | 0 |
| Accounts receivable | -12,988 | -12,222 | -31,769 | 33,384 | 33,528 |
| Other Working Capital | -66,814 | -100,873 | -89,712 | 36,018 | 52,821 |
| Other Operating Activity | 76,386 | 52,452 | 49,668 | 3,841 | -26,550 |
| Operating Cash Flow | $-165,306 | $-176,295 | $-137,929 | $-97,494 | $-23,795 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 130,610 | 103,691 | N/A | 243,269 | 180,091 |
| PPE Investments | -6,435 | -3,906 | -1,928 | -1,606 | -776 |
| Net Acquisitions | N/A | N/A | N/A | 6,147 | N/A |
| Purchase Of Investment | 0 | 0 | N/A | -224,216 | -172,438 |
| Sale Of Investment | 64,721 | 64,721 | 112,401 | 13,000 | 13,000 |
| Investing Cash Flow | $188,896 | $164,506 | $110,473 | $36,594 | $19,877 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -15,000 | -15,000 | -15,000 | -19 | -13 |
| Common Stock Issued | 9,978 | 9,783 | 553 | 96,581 | 96,490 |
| Common Stock Repurchased | -426 | -426 | N/A | N/A | 0 |
| Financing Cash Flow | $-5,448 | $-5,643 | $-14,447 | $96,562 | $96,477 |
| Beginning Cash Position | 107,099 | 107,099 | 107,099 | 71,437 | 71,437 |
| End Cash Position | 125,241 | 89,667 | 65,196 | 107,099 | 163,996 |
| Net Cash Flow | $18,142 | $-17,432 | $-41,903 | $35,662 | $92,559 |
| Free Cash Flow | |||||
| Operating Cash Flow | -165,306 | -176,295 | -137,929 | -97,494 | -23,795 |
| Capital Expenditure | -6,435 | -3,906 | -1,928 | -1,606 | -776 |
| Free Cash Flow | -171,741 | -180,201 | -139,857 | -99,100 | -24,571 |